The infusion pumps market is experiencing significant growth due to the increasing demand for advanced healthcare solutions, particularly in the management of chronic diseases and critical care.

Growth is driven by the rising prevalence of diabetes among the elderly, necessitating efficient insulin delivery solutions ...

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and ...